ARCHIVES

Alimta Granted Approval As NSCLC Continuation Therapy

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Forms Office of Combination Products;

January 10, 2003

NEW OIG Awards Bring Total to 58

November 13, 1987

NHIS Cancer Control Supplement To Survey 52,000

October 4, 1985

Low Adiponcetin Hormone Levels Linked to Increased Cancer Risk

January 25, 2013

NCI Official Says He Hopes to “Put More Money” Into SPOREs.

April 14, 2006

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003